Establishes an emergency insulin program

This bill establishes a state-run emergency insulin program to provide affordable access to analog insulins (life-saving prescription medications for managing type 1 and insulin-dependent type 2 diabetes) for uninsured or underinsured individuals at risk of serious health complications. It creates an emergency insulin program trust fund (funded by state appropriations and contributions from insulin manufacturers) to cover costs, allowing pharmacies with 20+ locations and certain facilities to dispense insulin without individual prescriptions through a sliding-scale cost-sharing system capped at $100 for a 30-day supply. The program must be operational by April 1, 2026, and requires the health commissioner to report annually on program participation, insulin types distributed, costs, and public-private partnerships. The bill directly affects vulnerable diabetic patients and healthcare providers participating in the program, focusing on immediate emergency access rather than long-term coverage changes.